Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children
European Journal of Cancer2020Vol. 139, pp. 135–148
Citations Over TimeTop 16% of 2020 papers
Andrew D.J. Pearson, Kimberly Stegmaier, Franck Bourdeaut, Gregory H. Reaman, Delphine Heenen, Michael L. Meyers, Scott A. Armstrong, Patrick A. Brown, Daniel D. De Carvalho, Nada Jabado, Lynley V. Marshall, Miguel N. Rivera, Malcolm A. Smith, Peter C. Adamson, Amy Barone, Christian Baumann, Samuel C. Blackman, Victoria Buenger, Martha Donoghue, Aundrietta D. Duncan, Elizabeth Fox, Brian Gadbaw, Maureen M. Hattersley, Peter Ho, Ira Jacobs, Michael J. Kelly, Mark W. Kieran, Giovanni Lesa, Franca Ligas, Donna Ludwinski, Joe McDonough, Zariana Nikolova, Koen Norga, Adrian M. Senderowicz, Tilmann Taube, Susan Weiner, Dominik Karres, Gilles Vassal
Related Papers
- → A Structural Insight into Hydroxamic Acid Based Histone Deacetylase Inhibitors for the Presence of Anticancer Activity(2013)65 cited
- Potential non-oncological applications of histone deacetylase inhibitors.(2011)
- Design, synthesis, and biological evaluation of N-hydroxycinnamamide/salicylic acid hybrids as histone deacetylase inhibitors(2014)
- → Synthesis, characterization, and vitro evaluation of new materials in vorinostat analogs containing biomolecules(2021)2 cited
- Progress in clinical trial of histone deacetylase (HDAC) inhibitors for non-small cell lung cancers*(2014)